NBIX: Koefisien rega marang pendapatan Neurocrine Biosciences Inc

Tandha merek Neurocrine (NBIX)

Neurocrine Biosciences (NBIX) minimizes capital expenditures by outsourcing manufacturing and clinical trials to external partners. The current P/S multiple illustrates the balance between market expectations and actual sales, where 4.50 determines the current status of the parameter. High patent scalability ensures massive profits with low costs, while the implementation of robotic laboratories significantly accelerates the screening of new neuropreparations.

NBIX (Neurocrine Biosciences Inc) riwayat Multiplikator P/S saka 04.07.2022 nganti 17.11.2026

Rincian analitis perusahaan Neurocrine Biosciences (NBIX)

Analisis umum perusahaan:NBIX, Neurocrine
Produk dadi Neurocrine Corp

Neurocrine Biosciences (NBIX) focuses on licensing agreements and an organic development pipeline, making revenue a key value driver since profits in biotech are often secondary. This multiple compares market capitalization to sales volume, demonstrating the premium investors are willing to pay for each unit of revenue, which clearly reflects the business valuation via the P/S ratio.

Pesaing Neurocrine Biosciences

BIIB (Biogen) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Regencell RGC|Kapitalisasi marang volume dodolan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Multiplikator P/S|XENE - Multiplikator P/S|VKTX: Multiplikator P/S|Rasio rega marang dodolan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Multiplikator P/S|DNLI: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan harmonybiosciences.com (HRMY)|Biohaven - Rasio kapitalisasi marang pendapatan|Multiplikator P/S AMLX (amylyx.com)|Trevi Pharma (TRVI) - Rega marang dodolan|Praxis Corp - Multiplikator P/S|Anavex Corp (AVXL) - Kapitalisasi marang pendapatan|CBLL: Multiplikator P/S|Prothena Biosciences - Rasio kapitalisasi pasar marang pendapatan|ALEC (alector.com) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan ANNX (Annexon Biosciences)|Rasio rega marang pendapatan Omeros Corporation (OMER)|Neurogene Corp - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan AC Immune S.A. ACIU|Koefisien rega marang pendapatan Voyager Therapeutics (VYGR)|Neumora - Multiplikator P/S|Rasio rega marang dodolan SCLX|Tevogen Bio Inc. (TVGN) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan ACOG|CGTX (cogrx.com) - Multiplikator P/S|Kapitalisasi marang pendapatan inhibikase.com (IKT)|Rasio rega marang pendapatan Cassava Sciences Inc (SAVA)|Koefisien rega marang pendapatan Assertio|Multiplikator P/S COYA (Coya Therapeutics, Inc.)|Kapitalisasi marang volume dodolan VTGN (VistaGen Therapeutics Inc)|OVID: Kapitalisasi marang pendapatan|ABOS: Rasio rega marang pendapatan|CervoMed (CRVO) - Rasio rega marang pendapatan|Rega marang dodolan Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan PEPG (PepGen)|Kapitalisasi marang pendapatan JUNS (Jupiter Neurosciences, Inc.)|Multiplikator P/S relmada.com (RLMD)|Rasio rega marang pendapatan Annovis Bio Corp ANVS|GRCE: Rasio kapitalisasi marang pendapatan|AIFF - Rasio rega marang pendapatan|KLTO (anewmeds.com) - Rasio kapitalisasi marang pendapatan|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalisasi marang pendapatan|revivapharma.com - Rasio kapitalisasi pasar marang pendapatan|MTVA (metaviatx.com) - Multiplikator P/S|NRXS: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S HSDT|PASG - Rega marang dodolan|Multiplikator P/S NEUP (Neuphoria Therapeutics)|NERV: Rasio kapitalisasi marang pendapatan|ATHA: Kapitalisasi marang pendapatan|Addex Therapeutics Ltd - Kapitalisasi marang volume dodolan|Alzamend Neuro, Inc. (ALZN) - Rasio rega marang pendapatan|CYCN (Cyclerion Therapeutics Inc.) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan PTIX|KTTA: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Brainstorm Cell Therapeutics, Inc. BCLI|Rasio kapitalisasi pasar marang pendapatan CARA|chromocell.com - Multiplikator P/S|Rasio rega marang dodolan ELYM|ITCI: Multiplikator P/S|Rega marang dodolan Longboard Pharmaceuticals, Inc. (LBPH)|Rasio rega marang pendapatan Marinus Pharmaceuticals, Inc.|NKGN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NRBO|SAGE: Rasio rega marang dodolan|Synaptogenix Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - Multiplikator P/S|Anew Medical (WENA) - Kapitalisasi marang pendapatan|CERE (Cerevel Corp) - Kapitalisasi marang pendapatan